Advertisement

Index by author

June 01, 2011; Volume 39,Issue 6

  1. Balani, Suresh K.

    1. A Refined Cytochrome P450 IC50 Shift Assay for Reliably Identifying CYP3A Time-Dependent Inhibitors
      Ping Li, Chuang Lu, Suresh K. Balani and Liang-Shang Gan
      Drug Metabolism and Disposition June 2011, 39 (6) 1054-1057; DOI: https://doi.org/10.1124/dmd.111.038208

  2. Banerjee, Subhashis

    1. Suppression of Cytochrome P450 Reductase (POR) Expression in Hepatoma Cells Replicates the Hepatic Lipidosis Observed in Hepatic POR-Null Mice
      Todd D. Porter, Subhashis Banerjee, Elzbieta I. Stolarczyk and Ling Zou
      Drug Metabolism and Disposition June 2011, 39 (6) 966-973; DOI: https://doi.org/10.1124/dmd.111.038562

  3. Behr, Melissa

    1. The Tissue-Specific Toxicity of Methimazole in the Mouse Olfactory Mucosa Is Partly Mediated through Target-Tissue Metabolic Activation by CYP2A5
      Fang Xie, Xin Zhou, Mary Beth Genter, Melissa Behr, Jun Gu and Xinxin Ding
      Drug Metabolism and Disposition June 2011, 39 (6) 947-951; DOI: https://doi.org/10.1124/dmd.110.037895

  4. Black, W. Cameron

    1. Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic Pathway
      Kelem Kassahun, W. Cameron Black, Deborah Nicoll-Griffith, Ian McIntosh, Nathalie Chauret, Stephen Day, Elizabeth Rosenberg and Kenneth Koeplinger
      Drug Metabolism and Disposition June 2011, 39 (6) 1079-1087; DOI: https://doi.org/10.1124/dmd.110.037184

  5. Brot, Nathan

    1. Studies on the Metabolism and Biological Activity of the Epimers of Sulindac
      David Brunell, Daphna Sagher, Shailaja Kesaraju, Nathan Brot and Herbert Weissbach
      Drug Metabolism and Disposition June 2011, 39 (6) 1014-1021; DOI: https://doi.org/10.1124/dmd.110.037663

  6. Brunell, David

    1. Studies on the Metabolism and Biological Activity of the Epimers of Sulindac
      David Brunell, Daphna Sagher, Shailaja Kesaraju, Nathan Brot and Herbert Weissbach
      Drug Metabolism and Disposition June 2011, 39 (6) 1014-1021; DOI: https://doi.org/10.1124/dmd.110.037663

  7. Buhimschi, Catalin S.

    1. ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy Condition
      Cifford W. Mason, Irina A. Buhimschi, Catalin S. Buhimschi, Yafeng Dong, Carl P. Weiner and Peter W. Swaan
      Drug Metabolism and Disposition June 2011, 39 (6) 1000-1007; DOI: https://doi.org/10.1124/dmd.111.038166

  8. Buhimschi, Irina A.

    1. ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy Condition
      Cifford W. Mason, Irina A. Buhimschi, Catalin S. Buhimschi, Yafeng Dong, Carl P. Weiner and Peter W. Swaan
      Drug Metabolism and Disposition June 2011, 39 (6) 1000-1007; DOI: https://doi.org/10.1124/dmd.111.038166

  9. Butler, Brendan F.

    1. Substituted Imidazole of 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates Cytochrome P450 2D6 by Protein Adduction
      Leslie D. Nagy, Catherine S. Mocny, Laura E. Diffenderfer, David J. Hsi, Brendan F. Butler, Evan J. Arthur, Kyle J. Fletke, Jairam R. Palamanda, Amin A. Nomeir and Laura Lowe Furge
      Drug Metabolism and Disposition June 2011, 39 (6) 974-983; DOI: https://doi.org/10.1124/dmd.110.037630
Back to top

In this issue

Advertisement